Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 282 | 676 | 951 | 760 | 817 |
| TOTAL | $342 | $736 | $957 | $760 | $817 |
| Non-Current Assets | |||||
| Intangibles | 5 | 5 | 5 | 5 | 5 |
| TOTAL | $5 | $5 | $5 | $5 | $5 |
| Total Assets | $347 | $742 | $962 | $766 | $823 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 459 | 559 | 334 | 343 | 199 |
| Accrued Expenses | 535 | 8 | 27 | 8 | 1 |
| Other current liabilities | 943 | 809 | 1,782 | 1,332 | 1,447 |
| TOTAL | $1,937 | $1,377 | $2,143 | $1,684 | $1,646 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,937 | $1,377 | $2,143 | $1,684 | $1,646 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94 | 93 | 90 | 87 | 83 |
| Common Shares | 35 | 34 | 33 | 32 | 31 |
| Retained earnings | -10,261 | -9,041 | -8,132 | -7,307 | -6,962 |
| TOTAL | $-1,590 | $-635 | $-1,181 | $-918 | $-824 |
| Total Liabilities And Equity | $347 | $742 | $962 | $766 | $823 |